USPTO 2015–2025 USPTO PatentsView Foreign Corporation

KEN DALL Enterprise Co., Ltd.

USPTO PatentsView assignee record - 10 granted patents across 3 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

10
Total patents granted
3
CPC technology areas
5.2
Avg claims per patent
-33%
5-year filing velocity

The verdict

KEN holds 10 US patents across 3 technology areas, rank #26,653 of 50,000 tracked assignees.

#26,653
of 50,000 US assignees by volume
Top 64%
by Innovation Score (30.9/100)
5.2
avg claims per patent
-33%
filing velocity, last 5 yrs

Portfolio overview

KEN DALL Enterprise Co., Ltd. has been granted 10 US utility patents between 2015 and 2025, placing KEN DALL Enterprise Co., Ltd. at rank #26,653 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.2 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, KEN DALL Enterprise Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, KEN sits between Karius, Inc. (10 patents, rank #26,649) and Kettler International, Inc. (10 patents, rank #26,657) - the closest US assignees by grant volume. The composite Innovation Score of 30.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 6 in the 2015–2019 window, a -33% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. KEN DALL Enterprise Co., Ltd.'s 5.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark KEN DALL Enterprise Co., Ltd. against peers pursuing similar technology classes.

Who files at KEN's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows KEN holds 10 patents at rank #26,653, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

KEN's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

31 Top 64% higher than 36% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201520172018202120222025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
KEN DALL Enterprise Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 20.0%
2017 2 20.0%
2018 2 20.0%
2021 1 10.0%
2022 2 20.0%
2025 1 10.0%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Declining

Where it ranks

Overall rank by patents

#26,653

Across all tracked assignees

Innovation Score

30.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does KEN DALL Enterprise Co., Ltd. hold?
KEN DALL Enterprise Co., Ltd. holds 10 US granted patents filed between 2015 and 2025, spanning 3 technology areas.
What is KEN DALL Enterprise Co., Ltd.'s Innovation Score?
KEN DALL Enterprise Co., Ltd. has an Innovation Score of 30.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does KEN DALL Enterprise Co., Ltd. focus on?
KEN DALL Enterprise Co., Ltd.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 9 patents. The company has filed patents in 3 CPC subclasses total.
Is KEN DALL Enterprise Co., Ltd.'s patent filing rate increasing or decreasing?
KEN DALL Enterprise Co., Ltd.'s recent filing velocity is -33% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for KEN DALL Enterprise Co., Ltd.'s patents?
KEN DALL Enterprise Co., Ltd.'s patents average 5.2 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the KEN DALL Enterprise Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

KEN's 10 grants land it in the top 64% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - KEN ranks #26,653 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.